Furthermore, high expression of CTLA-4 in HCC patients inhibits activation of T cell antigen presentation and proliferation and induces apoptosis, leading to immunosuppression and HCC development and progression [43]. This evidence concerns the gene CTLA4 and hepatocellular carcinoma.